Citadel Advisors
VIVO

Citadel Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Citadel Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,100
Closed -$69.7K – 16158
2022
Q4 		$69.7K Buy
+2,100
New +$67.6K ﹤0.01% 11705
2022
Q3 		– Sell
-30,000
Closed -$913K – 14074
2022
Q2 		$913K Sell
30,000
-5,700
-16% -$154K ﹤0.01% 7224
2022
Q1 		$927K Sell
35,700
-23,000
-39% -$547K ﹤0.01% 7883
2021
Q4 		$1.2M Sell
58,700
-80,200
-58% -$1.54M ﹤0.01% 7506
2021
Q3 		$2.67M Buy
138,900
+93,700
+207% +$1.87M ﹤0.01% 5642
2021
Q2 		$1M Buy
45,200
+22,300
+97% +$473K ﹤0.01% 8371
2021
Q1 		$601K Sell
22,900
-11,000
-32% -$262K ﹤0.01% 9290
2020
Q4 		$634K Buy
33,900
+13,300
+65% +$248K ﹤0.01% 7705
2020
Q3 		$350K Sell
20,600
-11,100
-35% -$216K ﹤0.01% 7888
2020
Q2 		$738K Buy
31,700
+15,800
+99% +$229K ﹤0.01% 6387
2020
Q1 		$134K Buy
+15,900
New +$134K ﹤0.01% 8390
2019
Q3 		– Sell
-16,100
Closed -$191K – 9948
2019
Q2 		$191K Sell
16,100
-1,700
-10% -$20.5K ﹤0.01% 8225
2019
Q1 		$313K Buy
+17,800
New +$296K ﹤0.01% 7559
2018
Q4 		– Sell
-22,200
Closed -$331K – 9977
2018
Q3 		$331K Buy
22,200
+8,200
+59% +$127K ﹤0.01% 7413
2018
Q2 		$223K Buy
+14,000
New +$209K ﹤0.01% 7706
2016
Q1 		– Sell
-1,500
Closed -$31K – 8306
2015
Q4 		$31K Buy
1,500
+1,000
+200% +$19.2K ﹤0.01% 7652
2015
Q3 		$9K Sell
500
-700
-58% -$12.8K ﹤0.01% 8509
2015
Q2 		$22K Buy
1,200
+800
+200% +$14.8K ﹤0.01% 8114
2015
Q1 		$8K Sell
400
-600
-60% -$11.1K ﹤0.01% 8252
2014
Q4 		$16K Sell
1,000
-800
-44% -$13.7K ﹤0.01% 7969
2014
Q3 		$32K Sell
1,800
-2,800
-61% -$55K ﹤0.01% 7183
2014
Q2 		$95K Buy
4,600
+1,800
+64% +$37K ﹤0.01% 6272
2014
Q1 		$61K Sell
2,800
-400
-13% -$9.17K ﹤0.01% 6613
2013
Q4 		$85K Hold
3,200
– – ﹤0.01% 5733
2013
Q3 		$76K Buy
3,200
+2,800
+700% +$65.4K ﹤0.01% 5546
2013
Q2 		$9K Buy
+400
New +$8.63K ﹤0.01% 6269

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's VIVO Position: Q1 2023 in Review

Citadel Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 125,670 shares — an estimated $4.17M sold.

Citadel Advisors first reported a position in VIVO in Q2 2013 and held it in 37 quarters. The position peaked at $5.15M in Q2 2016. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Citadel Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 125,670 Meridian Bioscience Inc shares in Q1 2023, an estimated $4.17M.
  • Citadel Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 37 quarters.
  • Citadel Advisors's Meridian Bioscience Inc position peaked at $5.15M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.